MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/95/0.1/21.03.25 Share Price

Warrant

DE000MG4D2D9

Market Closed - Börse Stuttgart 19:56:51 08/07/2024 BST
0.33 EUR -13.16% Intraday chart for MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/95/0.1/21.03.25
Current month-10.81%
1 month-63.33%
Date Price Change
08/07/24 0.33 -13.16%
05/07/24 0.38 0.00%
03/07/24 0.38 +2.70%
02/07/24 0.37 -9.76%
01/07/24 0.41 +10.81%

Delayed Quote Börse Stuttgart

Last update July 08, 2024 at 07:56 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG4D2D
ISINDE000MG4D2D9
Date issued 16/05/2024
Strike 95 $
Maturity 21/03/2025 (256 Days)
Parity 10 : 1
Emission price 2.16
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.13
Lowest since issue 0.33
Spread 0.03
Spread %8.11%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
57.22 USD
Average target price
83.43 USD
Spread / Average Target
+45.81%
Consensus